Metabolic Response to NAD Depletion across Cell Lines Is Highly Variable

by Xiao, Yang, Kwong, Mandy, Daemen, Anneleen, Belvin, Marcia, Liang, Xiaorong, Hatzivassiliou, Georgia, O’Brien, Thomas
Published 2016

Live-Cell Microscopy Reveals Small Molecule Inhibitor Effects on MAPK Pathway Dynamics

by Anderson, Daniel J., Durieux, Jenni K., Song, Kyung, Alvarado, Ryan, Jackson, Peter K., Hatzivassiliou, Georgia, Ludlam, Mary J. C.
Published 2011

Bax and Bak can localize to the endoplasmic reticulum to initiate apoptosis

by Zong, Wei-Xing, Li, Chi, Hatzivassiliou, Georgia, Lindsten, Tullia, Yu, Qian-Chun, Yuan, Junying, Thompson, Craig B.
Published 2003

Metabolic and transcriptional profiling reveals pyruvate dehydrogenase kinase 4 as a mediator of epithelial-mesenchymal transition and drug resistance in tumor cells

by Sun, Yuting, Daemen, Anneleen, Hatzivassiliou, Georgia, Arnott, David, Wilson, Catherine, Zhuang, Guanglei, Gao, Min, Liu, Peter, Boudreau, Aaron, Johnson, Leisa, Settleman, Jeff
Published 2014

Improved anti-tumor immunity and efficacy upon combination of the IDO1 inhibitor GDC-0919 with anti-PD-l1 blockade versus anti-PD-l1 alone in preclinical tumor models

by Spahn, Jessica, Peng, Jing, Lorenzana, Edward, Kan, David, Hunsaker, Thomas, Segal, Ehud, Mautino, Mario, Brincks, Erik, Pirzkall, Andrea, Kelley, Sean, Mahrus, Sami, Liu, Liling, Dale, Stephanie, Quiason, Cristine, Jones, Elizabeth, Liu, Yichin, Latham, Sheerin, Salphati, Laurent, DeMent, Kevin, Merchant, Mark, Hatzivassiliou, Georgia
Published 2015